Neuberger Berman Canada’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
NC
Neuberger Berman Canada's TEVA Position: Q3 2017 in Review
Neuberger Berman Canada sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2017, closing a stake of 19,000 shares — an estimated $631K sold.
Neuberger Berman Canada first reported a position in TEVA in Q1 2016 and held it in 6 quarters. The position peaked at $2.35M in Q4 2016. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.
- Neuberger Berman Canada reported no remaining Teva Pharmaceutical Industries position as of Q3 2017 after selling out during the quarter.
- Neuberger Berman Canada sold 19,000 Teva Pharmaceutical Industries shares in Q3 2017, an estimated $631K.
- Neuberger Berman Canada first reported a position in Teva Pharmaceutical Industries in Q1 2016 and held it in 6 quarters.
- Neuberger Berman Canada's Teva Pharmaceutical Industries position peaked at $2.35M in Q4 2016.
- 536 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2017.
Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.